Virus safety of human blood, plasma, and derived products

被引：16

作者：

Guertler, LG ^{[1
]}

机构：

[1] Univ Greifswald, Friedrich Loeffler Inst Med Microbiol, D-17489 Greifswald, Germany

来源：

THROMBOSIS RESEARCH | 2002年 / 107卷

关键词：

blood born viruses; NAT screening; antibody screening; infectivity of blood; infectivity of blood components; virus inactivation; virus vaccination;

D O I：

10.1016/S0049-3848(02)00151-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The reconstitution of blood and its components is hampered by factors of compatibility, availability, and the risk of transmission of infectious diseases. Protozoal agents such as plasmodium malariae and trypanosoma cruzi are only regionally relevant. Bacterial transmissions are easy to prevent and treat. Antibody, antigen, and nucleic acid screening have been implemented to prevent transmission of blood-borne viruses. Trans fusion-relevant viruses include hepatitis B and C virus (HBV and HCV), human immunodeficiency virus (HIV), human T leukemia virus (HTLV-I), and in certain circumstances, parvovirus B19, hepatitis A virus (HAV), and cytomegalovirus (CMV). Of great concern is the possible transmission of prion protein causing transmissible spongiform encephalopathy. Of future interest will be whether other viruses such as Nipah and Hendra virus are blood-borne and whether viruses such as TT, SEN, and GBV-C are involved in diseases or their progression, while not causing hepatitis. (C) 2002 Published by Elsevier Science Ltd.

引用

页码：S39 / S45

页数：7

共 24 条

[1] Transmission dynamics and epidemiology of BSE in British cattle [J].

Anderson, RM ;

Donnelly, CA ;

Ferguson, NM ;

Woolhouse, MEJ ;

Watt, CJ ;

Udy, HJ ;

MaWhinney, S ;

Dunstan, SP ;

Southwood, TRE ;

Wilesmith, JW ;

Ryan, JBM ;

Hoinville, LJ ;

Hillerton, JE ;

Austin, AR ;

Wells, GAH .

NATURE, 1996, 382 (6594) :779-788

[2] SAFETY AND COST-EFFECTIVENESS OF SOLVENT-DETERGENT-TREATED PLASMA - IN SEARCH OF A ZERO-RISK BLOOD-SUPPLY [J].

AUBUCHON, JP ;

BIRKMEYER, JD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (15) :1210-1214

[3] Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans [J].

Bendinelli, M ;

Pistello, M ;

Maggi, F ;

Fornai, C ;

Freer, G ;

Vatteroni, ML .

CLINICAL MICROBIOLOGY REVIEWS, 2001, 14 (01) :98-+

[4] Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection [J].

ConryCantilena, C ;

VanRaden, M ;

Gibble, J ;

Melpolder, J ;

Shakil, AO ;

Viladomiu, L ;

Cheung, L ;

DiBisceglie, A ;

Hoofnagle, J ;

Shih, JW ;

Kaslow, R ;

Ness, P ;

Alter, HJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (26) :1691-1696

[5]

DEKABAN G, 1996, HUMAN T CELL LYMPHOT, V1, P11

[6] PREVENTION OF PRIMARY CYTOMEGALOVIRUS-INFECTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION BY USING LEUKOCYTE-POOR RANDOM BLOOD PRODUCTS FROM CYTOMEGALOVIRUS-UNSCREENED BLOOD-BANK DONORS [J].

DEWITTE, T ;

SCHATTENBERG, A ;

VANDIJK, BA ;

GALAMA, J ;

OLTHUIS, H ;

VANDERMEER, JWW ;

KUNST, VAJM .

TRANSPLANTATION, 1990, 50 (06) :964-968

[7] THE RISK OF TRANSFUSION-TRANSMITTED INFECTION [J].

DODD, RY .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (06) :419-421

[8] MORBIDITY OF CYTOMEGALO-VIRUS INFECTION IN RECIPIENTS OF HEART OR HEART-LUNG TRANSPLANTS WHO RECEIVED CYCLOSPORINE [J].

DUMMER, JS ;

WHITE, LT ;

HO, M ;

GRIFFITH, BP ;

HARDESTY, RL ;

BAHNSON, HT .

JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (06) :1182-1191

[9] Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma [J].

Foreman, KE ;

Friborg, J ;

Kong, WP ;

Woffendin, C ;

Polverini, PJ ;

Nickoloff, BJ ;

Nabel, GJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (03) :163-171

[10] ANTIBODIES TO EPSTEIN-BARR VIRUS-ASSOCIATED NUCLEAR ANTIGEN IN INFECTIOUS-MONONUCLEOSIS [J].

HENLE, G ;

HENLE, W ;

HORWITZ, CA .

JOURNAL OF INFECTIOUS DISEASES, 1974, 130 (03) :231-239

← 1 2 3 →